WallStreetZenWallStreetZen

NASDAQ: CME
Cme Group Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for CME

Based on 9 analysts offering 12 month price targets for Cme Group Inc

Min Forecast
$252.00-5.68%
Avg Forecast
$290.67+8.79%
Max Forecast
$312.00+16.78%

Should I buy or sell CME stock?

Based on 9 analysts offering ratings for Cme Group Inc.

Buy
Strong Buy
3 analysts 33.33%
Buy
2 analysts 22.22%
Hold
3 analysts 33.33%
Sell
0 analysts 0%
Strong Sell
1 analysts 11.11%
Although CME's forecast from analysts indicates a "Buy", our proven Zen Rating quant model rates CME as a "Sell". Stocks with a Zen Rating of Sell have had an average return of -4.50% per year. Learn More

Be the first to know when Wall Street analysts revise their CME stock forecasts and price targets.

CME stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-10-13
lockedlocked$00.00+00.00%2025-10-08
lockedlocked$00.00+00.00%2025-10-01
lockedlocked$00.00+00.00%2025-09-25
lockedlocked$00.00+00.00%2025-09-25
UBS
Top 12%
89
HoldMaintains$285.00+6.67%2025-09-08
Oppenheimer
Top 11%
90
BuyMaintains$303.00+13.41%2025-07-24
Morgan Stanley
Top 24%
77
Strong BuyMaintains$304.00+13.78%2025-04-24
Keefe, Bruyette & Woods
Top 34%
67
HoldMaintains$273.00+2.18%2025-04-24

1 of 1

Forecast return on equity

Is CME forecast to generate an efficient return?

Company
17.28%
Industry
10.85%
Market
-65.75%
CME's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is CME forecast to generate an efficient return on assets?

Company
2.66%
Industry
10.52%
CME is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

CME earnings per share forecast

What is CME's earnings per share in the next 3 years based on estimates from 11 analysts?

Avg 1 year Forecast
$11.07+7%
Avg 2 year Forecast
$11.47+10.8%
Avg 3 year Forecast
$12.13+17.22%
CME's earnings are forecast to... subscribe to Premium to read more.
Forecast High Earnings Growth Forecast

CME revenue forecast

What is CME's revenue in the next 3 years based on estimates from 8 analysts?

Avg 1 year Forecast
$6.5B+0.83%
Avg 2 year Forecast
$6.8B+5.84%
Avg 3 year Forecast
$7.2B+11.43%
CME's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

CME earnings growth forecast

How is CME forecast to perform vs Financial Data & Stock Exchanges companies and vs the US market?

Company
5.26%
Industry
10.07%
Market
15.38%
CME's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Industry Forecast
CME's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Market Forecast
CME's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Savings Rate Forecast

CME revenue growth forecast

How is CME forecast to perform vs Financial Data & Stock Exchanges companies and vs the US market?

Company
3.64%
Industry
2.77%
Market
11.64%
CME's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
CME's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

CME vs Financial Datum & Stock Exchange Stocks

TickerPricePrice TargetUp/downsideConsensus
CME$267.18$290.67+8.79%Buy
ICE$158.27$200.43+26.64%Strong Buy
COIN$341.55$382.16+11.89%Buy
MCO$481.25$540.00+12.21%Buy
NDAQ$89.54$103.20+15.26%Strong Buy
View Top Financial Datum & Stock Exchange Stocks

Cme Group Stock Forecast FAQ

Is Cme Group Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 9 Wall Street analysts covering (NASDAQ: CME) stock is to Buy CME stock.

Out of 9 analysts, 3 (33.33%) are recommending CME as a Strong Buy, 2 (22.22%) are recommending CME as a Buy, 3 (33.33%) are recommending CME as a Hold, 0 (0%) are recommending CME as a Sell, and 1 (11.11%) are recommending CME as a Strong Sell.

If you're new to stock investing, here's how to buy Cme Group stock.

What is CME's earnings growth forecast for 2025-2027?

(NASDAQ: CME) Cme Group's forecast annual earnings growth rate of 5.26% is not forecast to beat the US Financial Data & Stock Exchanges industry's average forecast earnings growth rate of 10.07%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 15.38%.

Cme Group's earnings in 2025 is $3,721,400,000.On average, 11 Wall Street analysts forecast CME's earnings for 2025 to be $3,990,901,691, with the lowest CME earnings forecast at $3,924,520,003, and the highest CME earnings forecast at $4,061,463,768. On average, 12 Wall Street analysts forecast CME's earnings for 2026 to be $4,132,890,753, with the lowest CME earnings forecast at $3,949,746,486, and the highest CME earnings forecast at $4,346,162,648.

In 2027, CME is forecast to generate $4,372,218,001 in earnings, with the lowest earnings forecast at $4,089,681,391 and the highest earnings forecast at $4,677,710,710.

What is CME's revenue growth forecast for 2025-2027?

(NASDAQ: CME) Cme Group's forecast annual revenue growth rate of 3.64% is forecast to beat the US Financial Data & Stock Exchanges industry's average forecast revenue growth rate of 2.77%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 11.64%.

Cme Group's revenue in 2025 is $6,444,000,000.On average, 8 Wall Street analysts forecast CME's revenue for 2025 to be $2,341,553,868,138, with the lowest CME revenue forecast at $2,321,196,817,089, and the highest CME revenue forecast at $2,389,883,124,705. On average, 9 Wall Street analysts forecast CME's revenue for 2026 to be $2,458,004,359,101, with the lowest CME revenue forecast at $2,377,293,307,781, and the highest CME revenue forecast at $2,605,773,528,745.

In 2027, CME is forecast to generate $2,587,667,761,118 in revenue, with the lowest revenue forecast at $2,455,758,481,354 and the highest revenue forecast at $2,780,088,166,104.

What is CME's forecast return on assets (ROA) for 2025-2028?

(NASDAQ: CME) forecast ROA is 2.66%, which is lower than the forecast US Financial Data & Stock Exchanges industry average of 10.52%.

What is CME's Price Target?

According to 9 Wall Street analysts that have issued a 1 year CME price target, the average CME price target is $290.67, with the highest CME stock price forecast at $312.00 and the lowest CME stock price forecast at $252.00.

On average, Wall Street analysts predict that Cme Group's share price could reach $290.67 by Oct 13, 2026. The average Cme Group stock price prediction forecasts a potential upside of 8.79% from the current CME share price of $267.18.

What is CME's Earnings Per Share (EPS) forecast for 2025-2027?

(NASDAQ: CME) Cme Group's current Earnings Per Share (EPS) is $10.35. On average, analysts forecast that CME's EPS will be $11.07 for 2025, with the lowest EPS forecast at $10.89, and the highest EPS forecast at $11.27. On average, analysts forecast that CME's EPS will be $11.47 for 2026, with the lowest EPS forecast at $10.96, and the highest EPS forecast at $12.06. In 2027, CME's EPS is forecast to hit $12.13 (min: $11.35, max: $12.98).

What is CME's forecast return on equity (ROE) for 2025-2028?

(NASDAQ: CME) forecast ROE is 17.28%, which is considered weak.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.